Adaptive Natural Killer Cells Facilitate Effector Functions of Daratumumab in Multiple Myeloma

Abstract

Our findings indicate that adaptive NK cells are an important mediator of ADCC in multiple myeloma and support direct future efforts to better predict and improve the treatment outcome of daratumumab by selectively employing adaptive NK cells.